Future perspectives of non-invasive techniques for evaluating oocyte and embryo quality
-
ABSTRACT
Despite significant advancements in assisted reproductive technology, there is still high demand for improvements in the clinical pregnancy rate and reductions in the time needed to achieve a live birth. One bottleneck issue is the effective selection of oocytes and/or embryos of better quality in the laboratory. The quality of oocytes and embryos cannot be accurately assessed with routine clinical methods. Thus, assessment methods that are more objective, accurate, quantifiable, non-invasive, rapid, and repeatable are needed in the clinic. This perspective highlights the latest developments in non-invasive assessments of oocyte and embryo quality and presents new trends and insights into the biomedical engineering technologies used to evaluate oocyte and embryo quality. -
-
REFERENCES
[1] Xu, H. (2023). The Innovation Conference 2023 for Medicine: Fostering collaborative solutions through thought-provoking questions. The Innovation Medicine 1 : 100044. DOI: 10.59717/j.xinn-med.2023.100044. [2] Patrizio, P., and Sakkas, D. (2009). From oocyte to baby: A clinical evaluation of the biological efficiency of in vitro fertilization. Fertil. Steril. 91: 1061−1066. DOI: 10.1016/j.fertnstert.2008.01.003. [3] Yanez, L.Z., Han, J., Behr, B.B., et al. (2016). Human oocyte developmental potential is predicted by mechanical properties within hours after fertilization. Nat. Commun. 7: 10809. DOI: 10.1038/ncomms10809. [4] Marquet, P., Rappaz, B., Magistretti, P.J., et al. (2005). Digital holographic microscopy: A noninvasive contrast imaging technique allowing quantitative visualization of living cells with subwavelength axial accuracy. Opt. Lett. 30: 468−470. DOI: 10.1364/ol.30.000468. [5] Tan, T.C.Y., and Dunning, K.R. (2022). Non-invasive assessment of oocyte developmental competence. Reprod. Fertil. Dev. 35: 39−50. DOI: 10.1071/RD22217. [6] Uyar, A., Torrealday, S., and Seli, E. (2013). Cumulus and granulosa cell markers of oocyte and embryo quality. Fertil. Steril. 99: 979−997. DOI: 10.1016/j.fertnstert.2013.01.129. [7] Sciorio, R., Miranian, D., and Smith, G.D. (2022). Non-invasive oocyte quality assessment. Biol. Reprod. 106: 274−290. DOI: 10.1093/biolre/ioac009. [8] Huang, T., Xu, H., Wang, H., et al. (2023). Artificial intelligence for medicine: Progress, challenges, and perspectives. The Innovation Medicine 1 : 100030. DOI: 10.59717/j.xinn-med.2023.100030. [9] Xu, H., Feng, G., Shi, L., et al. (2023). PCOSt: A non-invasive and cost-effective screening tool for polycystic ovary syndrome. The Innovation 4: 100407. DOI: 10.1016/j.xinn.2023.100407. [10] Xu, H., Feng, G., Yang, R., et al. (2023). OvaRePred: Online tool for predicting the age of fertility milestones. The Innovation 4: 100490. DOI: 10.1016/j.xinn.2023.100490. -
ABOUT THIS ARTICLE
Cite this article:
Zeng Y., Cai B., Ding C., et al., (2024). Future perspectives of non-invasive techniques for evaluating oocyte and embryo quality. The Innovation Medicine 2(1): 100055. https://doi.org/10.59717/j.xinn-med.2024.100055
Welcome!
To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.
Export File
Citation
Zeng Y., Cai B., Ding C., et al., (2024). Future perspectives of non-invasive techniques for evaluating oocyte and embryo quality. The Innovation Medicine 2(1): 100055. https://doi.org/10.59717/j.xinn-med.2024.100055
Format
Content
DownLoad:
-
Figure 1.
Non-invasive assessments for selection of high-quality oocytes and embryos.
